Invesco Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 916,420 shares of REGN stock, worth $748 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

916,420

Previous 986,068 7.06%

Holding current value

$748 Million

Previous $949 Million 1.49%

% of portfolio

0.21%

Previous 0.21%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $61.5 Million - $74.6 Million	-69,648 Reduced 7.06%	916,420 $963 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $200 Million - $220 Million	221,061 Added 28.9%	986,068 $949 Million
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $16.8 Million - $19.1 Million	21,659 Added 2.91%	765,007 $672 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $115 Million - $140 Million	-165,714 Reduced 18.23%	743,348 $612 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $17 Million - $20.2 Million	24,307 Added 2.75%	909,062 $653 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $131 Million - $159 Million	191,892 Added 27.7%	884,755 $727 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $36.4 Million - $39.5 Million	51,541 Added 8.04%	692,863 $500 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $7.54 Million - $9.51 Million	13,135 Added 2.09%	641,322 $442 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $13.8 Million - $18.7 Million	25,256 Added 4.19%	628,187 $371 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $8.76 Million - $10.3 Million	14,720 Added 2.5%	602,931 $421 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $56.4 Million - $69.6 Million	103,773 Added 21.42%	588,211 $371 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $14.9 Million - $17.7 Million	25,958 Added 5.66%	484,438 $293 Million
Q2 2021 Aug 17, 2021	SELL	$472.8 - $558.54 $5.14 Million - $6.07 Million	-10,864 Reduced 2.31%	458,480 $256 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $31.7 Million - $38.9 Million	70,883 Added 17.79%	469,344 $222 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $51.8 Million - $65.8 Million	108,214 Added 37.28%	398,461 $193 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $17 Million - $20.5 Million	31,119 Added 12.01%	290,247 $162 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $21.4 Million - $28 Million	-43,407 Reduced 14.35%	259,128 $162 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $2.29 Million - $3.37 Million	-6,820 Reduced 2.2%	302,535 $148 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $275 Million - $378 Million	-1,002,899 Reduced 76.43%	309,355 $116 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $8.76 Million - $10.2 Million	-32,019 Reduced 2.38%	1,312,254 $364 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $13.8 Million - $19.1 Million	46,055 Added 3.55%	1,344,273 $421 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $24.8 Million - $29.4 Million	66,786 Added 5.42%	1,298,218 $533 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $414 Million - $496 Million	1,231,432 New	1,231,432 $460 Million

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

85.8M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $87.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account